公开(公告)号：US20220277812A1

公开(公告)日：2022-09-01

申请号：US17626795

申请日：2020-07-10

Applicant: DEEP BIO INC. ,  GENCURIX INC.

Inventor： Jee Eun KIM ,  Byeongil KANG ,  Chang Dae LEE ,  Min Ah CHO

IPC: G16B40/10 ,  G16H50/70 ,  G16H50/20 ,  G16B20/20

Abstract: A method for automatically calculating a threshold for classifying clusters from a reference data set and processing data by using same, and a system for performing same is included herein. A data processing method using auto-thresholding includes the steps of receiving, by a data processing system, as an input, a plurality of individual numerical values included in a reference data set having two or more clusters; on the basis of each of the numerical values included in the reference data set received as an input, calculating, by the data processing system, a threshold for classifying a cluster of the reference data set; and classifying, by the data processing system, into different clusters by using the threshold, each of at least one data set to be analyzed, having a plurality of individual numerical values.

公开(公告)号：US20190352703A1

公开(公告)日：2019-11-21

申请号：US16304340

申请日：2017-05-25

Applicant: GENCURIX INC.

Inventor： Young Kee SHIN ,  Bohyun BYUN ,  Hyunjeung CHOI ,  Joon Seok CHOI ,  Young Ho MOON ,  Jong Heun LEE ,  Sang Rea CHO ,  Jee Eun KIM ,  Myungsun KIM

IPC: C12Q1/6827 ,  C12Q1/6886 ,  C12Q1/6874 ,  C12Q1/686 ,  C12Q1/6823

Abstract: The present invention relates to a composition for detecting an epidermal cell growth factor receptor gene mutation and to a kit comprising the composition and, more specifically, to a primer and probe set composition for detecting an epidermal cell growth factor gene mutation, and to a kit for detecting an EGFR gene mutation, comprising the composition. A method according to the present invention can not only predict and diagnose responsiveness to a therapeutic agent for the prognosis of a cancer patient, but also predict a cancer metastasis or relapse Thus, the method can be useful for the purposes of determining the need to administer an anticancer therapeutic agent and guiding the direction of future treatment, and for monitoring a cancer metastasis or relapse.